NCT00533949

Clinical Trial Information


Trial Number: NCT00533949 (ClinicalTrials.gov)
Disease Type:
  • Lung, Mediastinal and Pleural Neoplasm
Trial Title:
A Randomized Phase III Comparison of Standard-Dose (60 Gy) Versus High-Dose (74 Gy) Conformal Radiotherapy With Concurrent and Consolidation Carboplatin/Paclitaxel +/- Cetuximab (IND #103444) in Patients With Stage IIIA/IIIB Non-Small Cell Lung Cancer
Study ID:
RTOG-0617
Do any of the collaborative agreements between your Group and a collaborator for this trial have ANY implications or restriction:
Yes – The collaborator must review data submitted to the Archive only
Images are available?:
Yes


Datasets Linked to Trial

Title Description
NCT00533949-D3 This dataset will allow users to reproduce adverse event tables in trial NCT00533949.
NCT00533949-D2 This dataset will allow users to reproduce the adverse event tables in trial NCT00533949.
NCT00533949-D1 This dataset will allow users to reproduce the treatment comparison between arms in trial NCT00533949.